Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“ Nalmefene , as an opioid receptor modulator, could pharmacologically support the reduction of drinking by reducing the (anticipated) rewarding effects of alcohol and expanding the range of treatment options.”
“ Nalmefene increased brain activation in areas responsible for empathy, social cognition and behavior, which might help alleviating the reinforcing properties of alcohol.”
European Neuropsychopharmacology • 2019 | View Paper
“RESULTS Datasets from 18 participants were available and showed that in the presence of the al ohol infusion, n al mefene si gnificantly reduced the BOLD response in the striatal region of interest compared with placebo.”
International journal of molecular sciences • 2016 | View Paper
“ Nalmefene is an opioid antagonist which as a once-a-day tablet formulation has recently been approved for reducing ethanol intake in alcoholic subjects.”
Journal of controlled release : official journal of the Controlled Release Society • 2016 | View Paper
“ Nalmefene and CTOP/naltrindole dose-dependently reduced ethanol self-administration in nondependent and dependent animals, whereas nor-BNI selectively attenuated ethanol self-administration in ethanol-dependent animals without affecting the self-administration of nondependent animals.”
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology • 2008 | View Paper
“The results demonstrated that when responding maintained by both EtOH and saccharin are matched at basal levels, unilateral (1–60 μg) or bilateral (0.5–10 μg) microinjections of nalmefene into the NACC produced selective dose-dependent reductions on responding maintained by EtOH.”